Single‐dose NEPA versus an aprepitant regimen for prevention of chemotherapy‐induced nausea and vomiting in patients receiving moderately emetogenic chemotherapy

INTRODUCTION: Non‐inferiority of NEPA (fixed combination of NK(1) receptor antagonist (RA), netupitant, and 5‐HT(3)RA, palonosetron) versus an aprepitant regimen was previously shown in a pragmatic study in patients receiving anthracycline cyclophosphamide (AC) and non‐AC moderately emetogenic chemo...

Descripción completa

Detalles Bibliográficos
Autores principales: Zelek, Laurent, Navari, Rudolph, Aapro, Matti, Scotté, Florian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
RESEARCH ARTICLES
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10469631/
https://www.ncbi.nlm.nih.gov/pubmed/37537943
http://dx.doi.org/10.1002/cam4.6121

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10469631/
https://www.ncbi.nlm.nih.gov/pubmed/37537943
http://dx.doi.org/10.1002/cam4.6121

Ejemplares similares